WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at the Lazard Capital Markets Third Annual Life Sciences Conference at The New York Palace Hotel in New York City at 11:00 am (EST) on Wednesday, November 29, 2006. The audio presentation will be simultaneously available via webcast on the “Investors” home page at http://www.neurometrix.com.
